Flcn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Flcn Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
FLCN (Folliculin) is a tumor suppressor gene encoding a conserved protein that functions as a regulator of mTOR (mammalian target of rapamycin) signaling, AMPK (AMP-activated protein kinase) activity, and lysosomal function. While primarily studied in the context of Birt-Hogg-Dubé syndrome and renal tumorigenesis, emerging evidence links FLCN to neurodegenerative processes. [2]
| Attribute | Value | [3]
|-----------|-------| [4]
| Gene Symbol | FLCN |
| Full Name | Folliculin |
| Chromosomal Location | 17p11.2 |
| Entrez Gene ID | 201163 |
| UniProt ID | Q8IVG7 |
| Aliases | BHD, FLCN1, MGC19765 |
FLCN is a highly conserved protein with several key molecular functions:
| Partner | Function |
|---|---|
| FNIP1 | FLCN-interacting protein, regulates metabolism |
| FNIP2 | FLCN-interacting protein 2 |
| mTOR | Part of mTORC1/2 complexes |
| AMPK | Energy sensing kinase |
The mTOR pathway is central to neurodegeneration:
FLCN regulates the autophagy-lysosome pathway:
Flcn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Flcn Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.